Subgroup Analysis Comparing Obeticholic Acid versus Placebo for Fibrosis Improvement: a Post-hoc Analysis of the FLINT Trial

被引：0

作者：

Hameed, Bilal ^{[1
]}

Terrault, Norah ^{[1
]}

Loomba, Rohit ^{[2
]}

McCullough, Arthur J. ^{[3
]}

Abdelmalek, Manal F. ^{[4
]}

Kowdley, Kris V. ^{[5
]}

Tetri, Brent A. ^{[6
]}

Sanyal, Arun J. ^{[7
]}

Lee, Lois ^{[8
]}

Ferguson, Beatrice ^{[8
]}

Shringarpure, Reshma ^{[8
]}

Shapiro, David ^{[8
]}

Chalasani, Naga P. ^{[9
]}

机构：

[1] Univ Calif San Francisco, Sch Med, San Francisco, CA USA

[2] Univ Calif San Diego, La Jolla, CA 92093 USA

[3] Cleveland Clin, Cleveland, OH 44106 USA

[4] Duke Univ, Durham, NC USA

[5] Swedish Med Ctr, Seattle, WA USA

[6] St Louis Univ, St Louis, MO 63103 USA

[7] Virginia Commonwealth Univ, Richmond, VA USA

[8] Intercept Pharmaceut Inc, San Diego, CA USA

[9] Indiana Univ, Indianapolis, IN 46204 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1074

引用

页码：541A / 542A

页数：2